Literature DB >> 29129653

Targeting ncRNAs by plant secondary metabolites: The ncRNAs game in the balance towards malignancy inhibition.

Diana Gulei1, Nikolay Mehterov2, Seyed Mohammad Nabavi3, Atanas Georgiev Atanasov4, Ioana Berindan-Neagoe5.   

Abstract

The current trend of combining state of the art technologies with quondam treatments in order to overcome existing gaps in the clinical area determined an increased interest into polyphenols, common dietary phytochemicals, for the prevention and treatment of chronic diseases, especially cancer. The reemergence of polyphenols in the cancer field is sustained by advanced-omics technologies able to identify coding and non-coding genes and their related signaling pathways modulated by natural compounds. Identification of the structural correspondence between interacting molecules will allow the development of more targeted and informed therapeutic strategies for cancer management.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; MDR; Natural products; Phytochemicals; Polyphenols; miRNAs; ncRNAs

Mesh:

Substances:

Year:  2017        PMID: 29129653     DOI: 10.1016/j.biotechadv.2017.11.003

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  9 in total

Review 1.  Nanoscale delivery systems for microRNAs in cancer therapy.

Authors:  Sanda Boca; Diana Gulei; Alina-Andreea Zimta; Anca Onaciu; Lorand Magdo; Adrian Bogdan Tigu; Calin Ionescu; Alexandru Irimie; Rares Buiga; Ioana Berindan-Neagoe
Journal:  Cell Mol Life Sci       Date:  2019-10-21       Impact factor: 9.261

Review 2.  Overview upon miR-21 in lung cancer: focus on NSCLC.

Authors:  Cecilia Bica-Pop; Roxana Cojocneanu-Petric; Lorand Magdo; Lajos Raduly; Diana Gulei; Ioana Berindan-Neagoe
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

Review 3.  Current Insights into Oral Cancer Epigenetics.

Authors:  Alexandra Iulia Irimie; Cristina Ciocan; Diana Gulei; Nikolay Mehterov; Atanas G Atanasov; Diana Dudea; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

Review 4.  Anticancer Activity and Mechanism of Xanthohumol: A Prenylated Flavonoid From Hops (Humulus lupulus L.).

Authors:  Chuan-Hao Jiang; Tao-Li Sun; Da-Xiong Xiang; Shan-Shan Wei; Wen-Qun Li
Journal:  Front Pharmacol       Date:  2018-05-22       Impact factor: 5.810

5.  Inhibitory Effect of CAPE and Kaempferol in Colon Cancer Cell Lines-Possible Implications in New Therapeutic Strategies.

Authors:  Liviuta Budisan; Diana Gulei; Ancuta Jurj; Cornelia Braicu; Oana Zanoaga; Roxana Cojocneanu; Laura Pop; Lajos Raduly; Alexandru Barbat; Alin Moldovan; Cristian Moldovan; Adrian Bogdan Tigu; Calin Ionescu; Atanas G Atanasov; Alexandru Irimie; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2019-03-09       Impact factor: 5.923

Review 6.  Antioxidants: Scientific Literature Landscape Analysis.

Authors:  Andy Wai Kan Yeung; Nikolay T Tzvetkov; Osama S El-Tawil; Simona G Bungǎu; Mohamed M Abdel-Daim; Atanas G Atanasov
Journal:  Oxid Med Cell Longev       Date:  2019-01-08       Impact factor: 6.543

7.  Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer.

Authors:  Xiaohan Dong; Minghui Chang; Xingguo Song; Shanshan Ding; Li Xie; Xianrang Song
Journal:  Thorac Cancer       Date:  2020-12-28       Impact factor: 3.500

8.  Combined Therapy in Cancer: The Non-coding Approach.

Authors:  Diana Gulei; Ioana Berindan-Neagoe
Journal:  Mol Ther Nucleic Acids       Date:  2018-07-31       Impact factor: 8.886

9.  Hsa-miR-125b Therapeutic Role in Colon Cancer Is Dependent on the Mutation Status of the TP53 Gene.

Authors:  Diana Cenariu; Alina-Andreea Zimta; Raluca Munteanu; Anca Onaciu; Cristian Silviu Moldovan; Ancuta Jurj; Lajos Raduly; Alin Moldovan; Adrian Florea; Liviuta Budisan; Laura Ancuta Pop; Lorand Magdo; Mihai Tudor Albu; Rares Bogdan Tonea; Mihai-Stefan Muresan; Calin Ionescu; Bogdan Petrut; Rares Buiga; Alexandru Irimie; Diana Gulei; Ioana Berindan-Neagoe
Journal:  Pharmaceutics       Date:  2021-05-06       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.